#Spain #Barcelona #Advanced Therapies #Phacilitate

Advanced Therapies Europe 2025: A New Experience in Barcelona

Advanced Therapies Europe, a key event in the biotechnology and pharmaceutical sectors, is set to take place in Barcelona for the first time from September 2 to September 4, 2025. This year's conference will unfold at the prestigious Hotel Arts, Ritz-Carlton, and promises to deliver a fresh and impactful format aimed at fostering deep connections among industry leaders.

With a limited capacity of just 500 participants, the event emphasizes creating high-value interactions and driving innovation within the field. Every element of the agenda is carefully curated to facilitate meaningful conversations and connections among those shaping the future of cell and gene therapy.

Located in one of Europe’s fastest-growing biotechnology hubs, Advanced Therapies Europe will bring together decision-makers from various sectors, including biotechnology and pharmaceuticals, investors, regulatory agencies, academics, and manufacturing leaders. Participants can expect an immersive three-day experience filled with strategic networking opportunities, in-depth discussions on pressing industry topics, and avenues for forming pivotal partnerships.

Key themes of the conference will revolve around urgent industry issues such as investment trends, manufacturing strategies, clinical development, marketing challenges, emerging technologies, and the evolving global regulatory landscape. The agenda will feature comprehensive workshops, interactive sessions, and specialized roundtable discussions designed to encourage open dialogue and collaborative problem-solving.

Confirmed speakers embody a wealth of expertise from renowned companies, including Miguel Forte, CEO of Kiji Therapeutics; Thomas Carlsen, CEO of Novo Nordisk Cellerator; Ase Rosenqvist of Johnson & Johnson; Eleuterio Lombardo from Takeda; and Angela Vollstedt from Novartis. Their insights will undoubtedly enrich the conversations at the event.

In addition to the main program, two significant summits will return: the Women in Advanced Therapies Congress and the Investment Summit. These summits will provide dedicated spaces for mentorship, innovation, and strategic alignment, ensuring inclusivity and diversity in discussions.

Furthermore, the Innovation Exchange will also make a comeback with a reimagined format, spotlighting innovative biotech companies and connecting them directly with influential investors who are instrumental in shaping the industry's future.

Ingerid Sorgaard, Phacilitate's content director, expressed excitement about the revamped event, stating, "We have reinvented this year’s format to be even more dynamic and engaging while promoting genuine connections. It’s not merely about presenting content; it's about facilitating the right conversations in the right environments. From selected roundtables and deep-dive workshops to rooftop networking and interactive formats, every component is designed to create meaningful connections, new perspectives, and real collaboration."

With spots limited to just 500 attendees, early registration is recommended. The advance pricing offer is available until April 18, making now the perfect time to secure your place.

For more information on registration and to apply, please visit Advanced Therapies Europe official website. Don’t miss out on this unique opportunity to be part of the future of advanced therapies in a vibrant city that’s leading the way in biotechnology innovation.